GLP1R and type 2 diabetes mellitus: The glucagon-like peptide-1 receptor (GLP-1R), a class B G protein-coupled receptor (GPCR) expressed at high levels in pancreatic beta cells and at lower levels in anorectic centres in the brain, is a well-established target for pharmacological T2D treatment [3].